A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis Screening

ACS sensors · 2026 · vol. 11(3) , pp. 2707–2720 · doi:10.1021/acssensors.5c04674 · PMID:41818042
other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated deep summary by claude@2026-06, 2026-06-24 · read from full text

The paper develops and tests a proof-of-concept lateral flow assay for detecting endometriosis-associated mitochondrial DNA deletion mutations using cell-free mitochondria in plasma, with surface-enhanced resonance Raman scattering (SERRS) integrated to improve sensitivity. Gold nanoparticles functionalized with the near-infrared dye NIR 4f are read by confocal Raman microscopy with digital SERRS, and performance is compared within a PCR workflow against gel electrophoresis and colorimetry. Digital SERRS-LFA achieved a limit of detection of 5.6 × 10^2 input copies (about 109-fold better than colorimetry) and an LOD of 0.35% when mutant DNA was tested against background wild-type DNA (about 14-fold better). The study presents analytical proof-of-concept and limitation in that it is not described as validated on patient plasma cohorts in this text. This paper is centrally about endometriosis — it proposes a SERRS-based lateral flow assay targeting mitochondrial DNA deletion mutations for endometriosis screening.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis (EMT) is an incurable and painful chronic illness that affects approximately 10% of people assigned female at birth worldwide. Currently, EMT takes on average 5-7 years to diagnose after histological confirmation with a tissue sample collected via laparoscopy. Therefore, there is a demand for developing new and powerful detection tools that can work in conjunction with imaging techniques to make EMT diagnosis more accessible and reduce diagnostic delays. This study proposes a proof-of-concept lateral flow assay (LFA) for the detection of an EMT biomarker based on mitochondrial DNA deletion mutations found in cell-free mitochondria in plasma. Surface-enhanced resonance Raman scattering (SERRS) was integrated with the LFA to increase sensitivity and allow quantitation using gold nanoparticles functionalised with the near-infrared fluorescent dye NIR 4f. The SERRS-LFA was compared to gel electrophoresis and colorimetry in a typical polymerase chain reaction (PCR) workflow. SERRS signals were analysed using confocal Raman microscopy in combination with digital SERRS. This digital SERRS-LFA demonstrated a limit of detection (LOD) of 5.6 × 102 input copies, about 109-fold lower than the reference colorimetric method. When mutant DNA was tested as abundance of background wild type DNA, an LOD of 0.35% was obtained, about 14-fold lower than the reference colorimetric method. Finally, quantitative analysis with a handheld Raman reader demonstrated the potential of bringing future amplification-free SERRS-based LFAs to point-of-care settings.
Full text 4,892 characters · extracted from oa-doi-fallback · click to expand
A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis ScreeningClick to copy article linkArticle link copied! - Laura M. Rey GomezLaura M. Rey GomezSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Laura M. Rey Gomez - Kazi Morshed AlomKazi Morshed AlomSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Kazi Morshed Alom - Audrey NadaliniAudrey NadaliniSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Audrey Nadalini - Su Su Thae HnitSu Su Thae HnitSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Su Su Thae Hnit - Benjamin ClarkBenjamin ClarkDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, UKMore by Benjamin Clark - Nana LyuNana LyuSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Nana Lyu - Rena HiraniRena HiraniSchool of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaAustralian Red Cross Lifeblood, Sydney, NSW 2015, AustraliaMore by Rena Hirani - Sian Sloan-DennisonSian Sloan-DennisonDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, UKMore by Sian Sloan-Dennison - Stacey LaingStacey LaingDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, UKMore by Stacey Laing - Cicely Rathmell - David Creasey - Dieter Bingemann - Jonathan FairclothJonathan FairclothWasatch Photonics, Morrisville, North Carolina 27560, USAMore by Jonathan Faircloth - Neil Shand - Duncan GrahamDuncan GrahamDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, UKMore by Duncan Graham - Karen FauldsKaren FauldsDepartment of Pure and Applied Chemistry, Technology and Innovation Centre, University of Strathclyde, Glasgow G1 1RD, UKMore by Karen Faulds - Yuling Wang*Yuling Wang*Email: [email protected]School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, Sydney, NSW 2109, AustraliaMore by Yuling Wang Abstract Endometriosis (EMT) is an incurable and painful chronic illness that affects approximately 10% of people assigned female at birth worldwide. Currently, EMT takes on average 5–7 years to diagnose after histological confirmation with a tissue sample collected via laparoscopy. Therefore, there is a demand for developing new and powerful detection tools that can work in conjunction with imaging techniques to make EMT diagnosis more accessible and reduce diagnostic delays. This study proposes a proof-of-concept lateral flow assay (LFA) for the detection of an EMT biomarker based on mitochondrial DNA deletion mutations found in cell-free mitochondria in plasma. Surface-enhanced resonance Raman scattering (SERRS) was integrated with the LFA to increase sensitivity and allow quantitation using gold nanoparticles functionalised with the near-infrared fluorescent dye NIR 4f. The SERRS-LFA was compared to gel electrophoresis and colorimetry in a typical polymerase chain reaction (PCR) workflow. SERRS signals were analysed using confocal Raman microscopy in combination with digital SERRS. This digital SERRS-LFA demonstrated a limit of detection (LOD) of 5.6 × 102 input copies, about 109-fold lower than the reference colorimetric method. When mutant DNA was tested as abundance of background wild type DNA, an LOD of 0.35% was obtained, about 14-fold lower than the reference colorimetric method. Finally, quantitative analysis with a handheld Raman reader demonstrated the potential of bringing future amplification-free SERRS-based LFAs to point-of-care settings. Cited By This article has not yet been cited by other publications. Article Views Altmetric Citations Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days. Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts. The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial DNA, Mitochondrial

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-30T06:11:02.404677+00:00
pubmed
last seen: 2026-06-30T06:06:41.600611+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine